Scarica l'app Stockscreener
17.91
1.86%
-0.34
Dopo l'orario di chiusura:
17.90
-0.01
-0.06%
Precedente Chiudi:
$18.25
Aprire:
$18.32
Volume 24 ore:
1.19M
Relative Volume:
0.79
Capitalizzazione di mercato:
$1.47B
Reddito:
$1.13B
Utile/perdita netta:
$62.75M
Rapporto P/E:
28.43
EPS:
0.63
Flusso di cassa netto:
$170.92M
1 W Prestazione:
+2.23%
1M Prestazione:
-16.78%
6M Prestazione:
-20.86%
1 anno Prestazione:
-9.64%
Intervallo 1D:
$17.79
$18.50
Intervallo di 1 settimana:
$17.16
$18.50
Portata 52W:
$16.75
$28.75
Progyny Inc Stock (PGNY) Company Profile
Nome
Progyny Inc
Settore
Industria
Telefono
212-888-3124
Indirizzo
1359 BROADWAY, NEW YORK, NY
Compare PGNY vs UNH, CVS, CI, ELV, HUM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
17.91 | 1.49B | 1.13B | 62.75M | 170.92M | 0.63 |
|
UNH
Unitedhealth Group Inc
|
282.34 | 258.84B | 447.57B | 12.81B | 16.08B | 13.19 |
|
CVS
Cvs Health Corp
|
76.32 | 99.56B | 402.11B | 1.73B | 7.81B | 1.3835 |
|
CI
Cigna Group
|
262.44 | 71.06B | 274.88B | 6.29B | 8.39B | 22.19 |
|
ELV
Elevance Health Inc
|
282.68 | 61.96B | 199.13B | 5.66B | 3.17B | 25.11 |
|
HUM
Humana Inc
|
173.62 | 21.53B | 126.36B | 1.30B | 1.55B | 10.67 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-20 | Aggiornamento | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2026-01-08 | Aggiornamento | Truist | Hold → Buy |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-11-12 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-07-08 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2024-12-02 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-11-13 | Downgrade | Truist | Buy → Hold |
| 2024-09-19 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-08-07 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-08-07 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2024-08-07 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-07-16 | Iniziato | JMP Securities | Mkt Outperform |
| 2024-05-10 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-09-27 | Iniziato | Canaccord Genuity | Buy |
| 2023-05-22 | Iniziato | BTIG Research | Buy |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-01-05 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2022-09-07 | Iniziato | Truist | Buy |
| 2021-12-02 | Iniziato | Jefferies | Buy |
| 2021-11-22 | Downgrade | Citigroup | Buy → Neutral |
| 2021-09-30 | Iniziato | Berenberg | Buy |
| 2021-08-12 | Iniziato | Barclays | Overweight |
| 2021-06-02 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-04-29 | Ripresa | JP Morgan | Overweight |
| 2021-03-10 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-07-01 | Iniziato | SVB Leerink | Outperform |
| 2020-06-02 | Iniziato | Guggenheim | Buy |
| 2019-11-19 | Iniziato | Citigroup | Buy |
| 2019-11-19 | Iniziato | Goldman | Buy |
| 2019-11-19 | Iniziato | JP Morgan | Overweight |
| 2019-11-19 | Iniziato | Piper Jaffray | Overweight |
| 2019-11-19 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Progyny Inc Borsa (PGNY) Ultime notizie
Quantbot Technologies Reduces Stake in Progyny - National Today
Progyny, Inc. Hits New 52-Week Low at $16.75 Amid Declining Performance - Markets Mojo
US Stocks Recap: Is Progyny Inc a good ESG investmentMarket Trend Summary & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Progyny's Valuation Upgrade Reflects Improved Financial Metrics Amid Market Dynamics - Markets Mojo
Will Progyny Inc. stock deliver strong dividend growthPortfolio Value Report & Reliable Breakout Stock Forecasts - Naître et grandir
Jefferies Maintains Buy on PGNY (Progyny, Inc.) March 2026 - Meyka
Jefferies cuts Progyny stock price target on guidance miss By Investing.com - Investing.com India
Jefferies cuts Progyny stock price target on guidance miss - Investing.com India
Progyny, Inc. Leadership to Participate in Key Investor Conferences in March 2026 - Quiver Quantitative
Progyny, Inc. Executives to Participate in Upcoming Investor Conferences - GlobeNewswire
Progyny leaders hit March healthcare stages on fertility tech - Stock Titan
BTIG Research Lowers Progyny (NASDAQ:PGNY) Price Target to $30.00 - MarketBeat
BTIG lowers Progyny stock price target to $30 on client loss impact - Investing.com Nigeria
Is Progyny (PGNY) Using Buybacks and Employee Stock Plans to Recast Its Growth Story? - Yahoo Finance
Progyny, Inc. (NASDAQ:PGNY) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Insider Selling: Progyny (NASDAQ:PGNY) EVP Sells 4,657 Shares of Stock - MarketBeat
Progyny (NASDAQ:PGNY) EVP Allison Swartz Sells 2,199 Shares - MarketBeat
[Form 4] Progyny, Inc. Insider Trading Activity - Stock Titan
Progyny (PGNY) EVP Allison Swartz receives equity grants and sells shares - Stock Titan
Progyny (NASDAQ: PGNY) CEO receives RSUs, options and withholds shares for taxes - Stock Titan
Allison C. Swartz sells shares; PGNY (NASDAQ: PGNY) Form 144 notice - Stock Titan
Progyny: Transitional Headwinds Hide An Undervalued Platform (NASDAQ:PGNY) - Seeking Alpha
Is Progyny (PGNY) Attractive After Recent Share Price Weakness And DCF Upside? - simplywall.st
Progyny, Inc. Hits Day Low of $16.75 Amid Price Pressure - Markets Mojo
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Arcellx Inc (ACLX), Alkermes (ALKS) and Progyny (PGNY) - The Globe and Mail
Allison Swartz to sell 4,657 PGNY shares (NASDAQ: PGNY) in vesting sale - Stock Titan
Progyny, Inc. (PGNY) Stock Analysis: Potential 68% Upside with Strong Buy Ratings in Healthcare Sector - DirectorsTalk Interviews
INVO Fertility's Wisconsin Clinic Joins Progyny Network - Bitget
INVO Fertility (IVF) Clinic Joins Progyny Network, Expanding Pat - GuruFocus
INVO Fertility’s Wisconsin Clinic Joins Progyny Network - marketscreener.com
Progyny deal brings INVO fertility care in-network in Wisconsin - Stock Titan
Progyny (PGNY): Truist Securities Lowers Price Target to $28 | P - GuruFocus
JPMorgan Chase & Co. Trims Position in Progyny, Inc. $PGNY - MarketBeat
Intech Investment Management Boosts Progyny Stake by 336% - National Today
Price-Driven Insight from (PGNY) for Rule-Based Strategy - Stock Traders Daily
PGNY (NASDAQ: PGNY) insider sale notice lists 2,199 common shares - Stock Titan
Does Progyny's (PGNY) Buyback and ESOP Shelf Quietly Reframe Its Growth Story? - simplywall.st
PGNY Sees Revised Price Target Despite Maintained Overweight Rat - GuruFocus
Progyny (NASDAQ:PGNY) Given New $28.00 Price Target at KeyCorp - MarketBeat
KeyBanc lowers Progyny stock price target on conservative estimates By Investing.com - Investing.com Canada
KeyBanc lowers Progyny stock price target on conservative estimates - Investing.com
Vanguard Group Inc. Has $217.48 Million Holdings in Progyny, Inc. $PGNY - MarketBeat
Truist Cuts Price Target on Progyny to $28 From $34, Keeps Buy Rating - marketscreener.com
Truist cuts Progyny stock price target on covered lives miss By Investing.com - Investing.com Australia
Truist cuts Progyny stock price target on covered lives miss - Investing.com
Intech Investment Management LLC Acquires 130,885 Shares of Progyny, Inc. $PGNY - MarketBeat
Short Interest in Progyny, Inc. (NASDAQ:PGNY) Increases By 41.0% - MarketBeat
Progyny (PGNY) Valuation In Focus After Recent Share Price Weakness - simplywall.st
Progyny, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Progyny (PGNY) Gets a Hold from Canaccord Genuity - The Globe and Mail
Analysts Have Conflicting Sentiments on These Healthcare Companies: Teladoc (TDOC) and Progyny (PGNY) - The Globe and Mail
Progyny Inc Azioni (PGNY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.66%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):